Approvals/TGA/INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation

Approved

STANDARD

INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cbd0b210abd61685
Product Name: INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation
Artg Id: 211601
Artg Name: INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2014-07-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a9b4684b42cc480e91da15388361c12e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/73c15579869465bb4ee707709f7d0c42.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

cbd0b210abd61685

Type

Standard